Skip to main content
Devonian Health Group Inc logo

Devonian Health Group Inc — Investor Relations & Filings

Ticker · GSD ISIN · CA2518341078 TSXV Manufacturing
Open in API
Filings indexed 598 across all filing types
Latest filing 2020-08-05 Regulatory Filings
Country CA Canada
Listing TSXV GSD

About Devonian Health Group Inc

https://groupedevonian.com/

Devonian Health Group Inc. is a clinical-stage botanical pharmaceutical company specializing in the development of novel prescription therapeutic solutions for unmet medical needs. The core business involves late-stage prescription botanical drugs targeting fibroinflammatory autoimmune diseases, with a focus on gastrointestinal, dermatological, and hepatologic conditions. The company utilizes a broad-based technology platform, originating from over 20 years of research, to develop therapies that target multiple cellular pathways and regulate genes linked to these diseases. Its pipeline includes the lead product candidate, Thykamine, currently in Phase 3 clinical trials. Devonian also develops high-value dermatological products alongside its core drug development activities.

Recent filings

Filing Released Lang Actions
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed instructions and fields related to filing reports of exempt distributions in Canadian jurisdictions. It includes regulatory references to Canadian securities laws and filing requirements for issuers and underwriters. The content is a regulatory form used for reporting exempt distributions of securities, not a financial report, earnings release, or management discussion. It is a regulatory filing form used for compliance purposes under Canadian securities regulations. Therefore, the document fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory compliance documents that do not fit other specific categories.
2020-08-05 English
News release - French.pdf
Regulatory Filings
2020-07-30 English
News release - English.pdf
Regulatory Filings
2020-07-28 English
52-109FV2 - Certification of interim filings - CEO (F).pdf
Regulatory Filings Classification · 95% confidence The document is an attestation signed by the President and CEO of GroupeSanté Devonian Inc. regarding the interim period ended April 30, 2020. It references "documents intermédiaires" (interim documents) and certifies that the information is not false or misleading and provides a true and fair view of the financial position and cash flows for the period. The document also mentions compliance with Regulation 52-109, which relates to certifications of interim and annual filings. The document length is only 1770 characters, which is quite short and primarily consists of a certification statement rather than substantive financial data or analysis. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself. Therefore, this document is a Regulatory Filing (RNS) consisting of an officer certification related to interim financial documents, not the interim report itself.
2020-06-25 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 85% confidence The document text is in a non-English language and appears to be a narrative or descriptive text rather than a structured financial report. The length is 3056 characters, which is relatively short. There are no clear indications of financial statements, fiscal periods, regulatory bodies, or specific report titles such as 10-K, IR, or ER. The text does not contain typical keywords or formatting associated with financial reports or announcements. Given the lack of identifiable financial data or report structure, and the short length, this document does not fit into any specific financial report category. It is best classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not neatly fit into other categories.
2020-06-25 English
52-109FV2 - Certification of interim filings - CFO (F).pdf
Regulatory Filings Classification · 100% confidence The document is an attestation by the interim Chief Financial Officer regarding the review of the interim financial report and interim management report for the period ended April 30, 2020. It explicitly states it is an attestation for an emerging issuer under Canadian National Instrument 52-109, which relates to certifications of interim and annual filings. The document does not contain actual financial statements or substantive financial data but is a certification of the interim documents. According to the Certification Rule, such attestations or officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is 3623 characters, which is relatively short and consistent with a certification rather than a full report. Therefore, the correct classification is Regulatory Filings (RNS).
2020-06-25 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.